
Vibose 0.2mg Tablet
Marketer
Synchroz Pharmaceuticals Private Limited
Salt Composition
Voglibose (0.2mg)
Overview Vibose 0.2mg Tablet
Acarbose 0.2mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating post-meal blood glucose spikes. It's indicated when dietary modifications and other similar treatments prove insufficient in controlling elevated blood sugar. Take Acarbose 0.2mg immediately before each meal; your physician will determine the appropriate dosage and frequency for optimal blood sugar control. Discontinue use only under your doctor's supervision, as abrupt cessation may elevate blood glucose, increasing the risk of serious complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Regular blood glucose monitoring is essential while using this medicine. Common side effects include gas, abdominal discomfort, appetite changes, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Acarbose itself doesn't cause hypoglycemia, concurrent use with other diabetes medications (especially insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective. Inform your doctor about any kidney or liver conditions before commencing treatment. Avoid use if you have bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or nursing women should seek medical advice prior to use. Always disclose all other medications to your physician to ensure safe usage. Limit alcohol consumption while taking this medication to minimize the risk of hypoglycemia.
Primary Ingredients of Vibose 0.2mg Tablet
The provided text is "undefined," so no rewriting is possible. There is no text to rephrase.
Uses of Vibose 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Vibose 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vibose 0.2mg tablets should be taken on an empty stomach.
Common Side effects of Vibose 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vibose 0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vibose 0.2mg Tablet on an empty stomach.
How Vibose 0.2mg Tablet works:
Januvia 0.2mg tablets are used to manage diabetes. They work by blocking enzymes in the gut that digest complex carbohydrates, thus reducing post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vibose 0.2mg Tablet with alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
Acarbose 0.2mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Vibose 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vibose 0.2mg tablets.
KidneyCAUTION
Acarbose 0.2mg tablets require careful administration in individuals with advanced renal impairment. Dosage modification for acarbose 0.2mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.2mg Vibose tablets cautiously. Dosage modification of 0.2mg Vibose tablets may be necessary. Physician consultation is advised.
What if you forget to take Vibose 0.2mg Tablet :
Omit any missed Vibose 0.2mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Vibose 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavior Class | Alpha-glucosidase inhibitors |
